Schedule 13G ownership disclosure

Intec Pharma Ltd.

Security class unavailable · CUSIP: M53644106

Event date: 2020-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,030,000
Percent of class
7.7500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000065
Form type
SC 13G
Filer
Intec Pharma Ltd.
CIK
CIK 1638381
Filed
Feb 05, 2020
Reporting period
Jan 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub